speb/financial-data huggingface dataset:
Financial ratios for MBLY — annual report dated 2024-12-31
Total revenue: 453150684.9315069
Gross profit: 203013698.630137
Operating income: -145205479.4520548
Net income: -846575342.4657534
Capital expenditures: 22191780.82191781
Operating cash flow: 109589041.09589042
Depreciation & amortization: 138630136.98630136
Net tangible assets: 624109589.0410959
Owner earnings: -730136986.3013699
Return on net tangible assets (%): -116.98858647936787
Buffett classification: The Gruesome
Stock price: 19.92
Shares outstanding: 252419583
Book value: 3311506849.3150687
P/B ratio: 1.5184018400565897
Market cap (USD): 5028198093.360001
Debt to equity: 0
Current ratio: 6.528528528528529
Quick ratio: 5.282282282282282
COGS to revenue (%): 55.199516324062884
R&D to revenue (%): 65.47762998790809
SG&A to revenue (%): 11.366384522370012
Free cash flow (dilution-adjusted): 10958904.10958904
Buyback yield (%): 0
Retained earnings: -838356164.3835616
Inventory turnover: 2.2
Receivables turnover: 7.80188679245283
Capitalized R&D asset: 535219752.80027246
ROCI (R&D-adjusted, %): -2.6726350240373673
Rosenberg metric: -0.35105783010000463
FCF margin (%): 2.4183796856106405
Revenue growth (%): -21.096417534773693
Rule of 40 score: -18.67803784916305
Financial ratios for MBLY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.92
Shares outstanding: 252419583
Market cap (USD): 5028198093.360001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MBLY — quarterly report dated 2025-03-31
Total revenue: 118699186.99186993
Gross profit: 56097560.97560976
Operating income: -31707317.073170733
Net income: -27642276.422764227
Capital expenditures: 3794037.940379404
Operating cash flow: 29539295.39295393
Depreciation & amortization: 34959349.593495935
Net tangible assets: 637127371.2737128
Owner earnings: 3523035.2303523044
Buffett classification: The Gruesome
Stock price: 14.4
Shares outstanding: 252419583
Book value: 3265311653.1165314
P/B ratio: 1.11316847558204
Market cap (USD): 3634841995.2000003
Debt to equity: 0
Current ratio: 7.637931034482758
Quick ratio: 6.382758620689654
COGS to revenue (%): 52.73972602739726
R&D to revenue (%): 62.78538812785388
SG&A to revenue (%): 11.187214611872145
Free cash flow (dilution-adjusted): 8130081.300813008
Buyback yield (%): 0
Retained earnings: -856910569.1056911
Inventory turnover: 0.6346153846153846
Receivables turnover: 2.0184331797235027
Capitalized R&D asset: 74525745.25745258
ROCI (R&D-adjusted, %): 0.5313893561910864
FCF margin (%): 6.8493150684931505
Rule of 40 score: 6.8493150684931505
Financial ratios for MBLY — quarterly report dated 2025-06-30
Total revenue: 149262536.87315634
Gross profit: 74336283.18584071
Operating income: -21828908.55457227
Net income: -19764011.79941003
Capital expenditures: 4129793.5103244837
Operating cash flow: 62831858.407079645
Depreciation & amortization: 38053097.34513274
Net tangible assets: 731268436.578171
Owner earnings: 14159292.035398224
Buffett classification: The Gruesome
Stock price: 17.98
Shares outstanding: 252419583
Book value: 3559292035.39823
P/B ratio: 1.2751142803690203
Market cap (USD): 4538504102.34
Debt to equity: 0
Current ratio: 6.9077809798270895
Quick ratio: 5.971181556195966
COGS to revenue (%): 50.19762845849802
R&D to revenue (%): 55.73122529644269
SG&A to revenue (%): 8.695652173913043
Free cash flow (dilution-adjusted): 38348082.595870204
Buyback yield (%): 0
Retained earnings: -952507374.6312684
Inventory turnover: 0.7815384615384615
Receivables turnover: 2.331797235023042
Capitalized R&D asset: 133118090.03045782
ROCI (R&D-adjusted, %): 0.23486258450023398
Rosenberg metric: 0.2447304907481899
FCF margin (%): 25.691699604743086
Revenue growth (%): 25.748575584919376
Rule of 40 score: 51.44027518966246
Financial ratios for MBLY — quarterly report dated 2025-09-30
Total revenue: 152265861.02719033
Gross profit: 73413897.28096677
Operating income: -32930513.59516616
Net income: -29003021.148036253
Capital expenditures: 7250755.287009063
Operating cash flow: 50453172.20543806
Depreciation & amortization: 38972809.667673714
Net tangible assets: 742900302.1148037
Owner earnings: 2719033.2326283986
Buffett classification: The Gruesome
Stock price: 14.12
Shares outstanding: 252419583
Book value: 3605740181.268882
P/B ratio: 0.9884695881514538
Market cap (USD): 3564164511.96
Debt to equity: 0
Current ratio: 6.459893048128343
Quick ratio: 5.609625668449198
COGS to revenue (%): 51.78571428571429
R&D to revenue (%): 60.317460317460316
SG&A to revenue (%): 9.523809523809524
Free cash flow (dilution-adjusted): 21450151.057401814
Buyback yield (%): 0.8476455074158155
Retained earnings: -1004531722.0543807
Inventory turnover: 0.8207547169811321
Receivables turnover: 2.5074626865671643
Capitalized R&D asset: 172170909.51141044
ROCI (R&D-adjusted, %): -0.6338159322105763
Rosenberg metric: -0.011088256090505844
FCF margin (%): 14.087301587301587
Revenue growth (%): 2.012108474738186
Rule of 40 score: 16.099410062039773
Financial ratios for MBLY — quarterly report dated 2025-12-31
Total revenue: 140251572.327044
Gross profit: 63522012.57861635
Operating income: -44025157.2327044
Net income: -39937106.91823899
Capital expenditures: 8490566.037735848
Operating cash flow: 35534591.19496855
Depreciation & amortization: 40880503.14465409
Net tangible assets: 790880503.144654
Owner earnings: -7547169.81132075
Return on net tangible assets (%): -0.9542743538767391
Buffett classification: The Gruesome
Stock price: 10.44
Shares outstanding: 252419583
Book value: 3736163522.0125785
P/B ratio: 0.7053386263726622
Market cap (USD): 2635260446.52
Debt to equity: 0
Current ratio: 6.1034482758620685
Quick ratio: 5.298029556650246
COGS to revenue (%): 54.7085201793722
R&D to revenue (%): 65.02242152466367
SG&A to revenue (%): 11.659192825112108
Free cash flow (dilution-adjusted): 4716981.13207547
Buyback yield (%): 0
Retained earnings: -1085534591.1949685
Inventory turnover: 0.746177370030581
Receivables turnover: 3.404580152671756
Capitalized R&D asset: 180181039.18950436
ROCI (R&D-adjusted, %): -1.0442956462036417
Rosenberg metric: -0.10770440251572336
FCF margin (%): 3.363228699551569
Revenue growth (%): -7.890336428072284
Rule of 40 score: -4.527107728520715
Financial ratios for MBLY — annual report dated 2025-12-31
Total revenue: 595597484.2767296
Gross profit: 284276729.5597484
Operating income: -138364779.8742138
Net income: -123270440.25157233
Capital expenditures: 24842767.295597482
Operating cash flow: 189308176.1006289
Depreciation & amortization: 162578616.35220125
Net tangible assets: 790880503.144654
Owner earnings: 14465408.805031445
Buffett classification: The Gruesome
Stock price: 10.44
Shares outstanding: 252419583
Book value: 3736163522.0125785
P/B ratio: 0.7053386263726622
Market cap (USD): 2635260446.52
Debt to equity: 0
Current ratio: 6.1034482758620685
Quick ratio: 5.298029556650246
COGS to revenue (%): 52.27032734952481
R&D to revenue (%): 60.77085533262936
SG&A to revenue (%): 10.190073917634635
Free cash flow (dilution-adjusted): 77358490.56603774
Buyback yield (%): 1.193299164112221
Retained earnings: -1085534591.1949685
Inventory turnover: 3.0275229357798166
Receivables turnover: 14.458015267175574
Capitalized R&D asset: 641788382.2726523
ROCI (R&D-adjusted, %): -1.751954633121428
Rosenberg metric: 0.27387817441651124
FCF margin (%): 12.988384371700107
Revenue growth (%): 31.43475318077768
Rule of 40 score: 44.42313755247778
Financial ratios for MLAB — annual report dated 2022-03-31
Total revenue: 184335000
Gross profit: 109090000
Operating income: 4702000
Net income: 1871000
Capital expenditures: 4432000
Operating cash flow: 39223000
Depreciation & amortization: 25068000
Net tangible assets: -147482000
Owner earnings: 22507000
Return on net tangible assets (%): -15.260845391301988
Capex to operating income (%): 94.2577626541897
Buffett classification: The Gruesome
Stock price: 248.97
P/E ratio: 735.1908450400856
Shares outstanding: 5524931
Book value: 393801000
P/B ratio: 3.4929877554145365
Market cap (USD): 1375542071.07
Debt to equity: 0.561534886909886
Current ratio: 2.586994069295599
Quick ratio: 2.074955779835605
Effective tax rate (%): 47.649692221600446
Interest coverage ratio: 1.2102960102960103
COGS to revenue (%): 40.819703257655895
R&D to revenue (%): 8.553448883825645
SG&A to revenue (%): 48.076057178506524
Free cash flow (dilution-adjusted): 23400000
Buyback yield (%): 0
Retained earnings: 76675000
Inventory turnover: 3.0579939852068603
Receivables turnover: 4.4715457015330875
Capitalized R&D asset: 15767000
ROCI (R&D-adjusted, %): 2.2535567336857847
FCF margin (%): 12.694279436894785
Rule of 40 score: 12.694279436894785
Financial ratios for MLAB — annual report dated 2023-03-31
Total revenue: 219080000
Gross profit: 133693000
Operating income: 3320000
Net income: 930000
Capital expenditures: 4544000
Operating cash flow: 27983000
Depreciation & amortization: 33134000
Net tangible assets: -109779000
Owner earnings: 29520000
Return on net tangible assets (%): -26.89038887218867
Capex to operating income (%): 136.86746987951807
Buffett classification: The Gruesome
Stock price: 171.29
P/E ratio: 1017.5972376236559
Shares outstanding: 5524931
Book value: 393480000
P/B ratio: 2.405116984319406
Market cap (USD): 946365430.99
Debt to equity: 0.4730608925485412
Current ratio: 2.743951659401739
Quick ratio: 1.944994118868055
Interest coverage ratio: 0.6960167714884696
COGS to revenue (%): 38.97526017893007
R&D to revenue (%): 9.352747854664962
SG&A to revenue (%): 50.15656381230601
Free cash flow (dilution-adjusted): 10901000
Buyback yield (%): 0
Retained earnings: 74199000
Inventory turnover: 2.4648403671843426
Receivables turnover: 5.148645155225494
Capitalized R&D asset: 31053890
ROCI (R&D-adjusted, %): 1.8050574216154982
Rosenberg metric: 1.5604109849686054
FCF margin (%): 4.975807924046011
Revenue growth (%): 18.84883500149185
Rule of 40 score: 23.82464292553786
Financial ratios for MLAB — annual report dated 2024-03-31
Total revenue: 216187000
Gross profit: 133250000
Operating income: 2458000
Net income: -254246000
Capital expenditures: 2567000
Operating cash flow: 44133000
Depreciation & amortization: 31574000
Net tangible assets: -148455000
Owner earnings: -225239000
Capex to operating income (%): 104.43449959316517
Buffett classification: The Gruesome
Stock price: 108.17
Shares outstanding: 5524931
Book value: 145393000
P/B ratio: 4.110457768049356
Market cap (USD): 597631786.27
Debt to equity: 1.5453563789178295
Current ratio: 2.4677739664199314
Quick ratio: 1.730389059397003
Interest coverage ratio: 0.4314551518342988
COGS to revenue (%): 38.363546374203814
R&D to revenue (%): 8.927456322535583
SG&A to revenue (%): 51.572018669022654
Free cash flow (dilution-adjusted): 29630000
Buyback yield (%): 0
Retained earnings: -183494000
Inventory turnover: 2.5382402448355013
Receivables turnover: 5.535450006401229
Capitalized R&D asset: 38231410
ROCI (R&D-adjusted, %): 0.7349413990311798
Rosenberg metric: -0.021620302586627622
FCF margin (%): 13.705726986359032
Revenue growth (%): -1.3205221836771954
Rule of 40 score: 12.385204802681837
Financial ratios for MLAB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 128.35
Shares outstanding: 5524931
Market cap (USD): 709124893.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLAB — quarterly report dated 2024-12-31
Total revenue: 62840000
Gross profit: 39754000
Operating income: 5779000
Net income: -1676000
Capital expenditures: 813000
Operating cash flow: 18129000
Depreciation & amortization: 5497000
Net tangible assets: -120119000
Owner earnings: 3008000
Capex to operating income (%): 14.068177885447309
Buffett classification: The Great
Stock price: 130.52
Shares outstanding: 5524931
Book value: 155214000
P/B ratio: 4.645933962915716
Market cap (USD): 721113994.12
Debt to equity: 1.3633563982630432
Current ratio: 0.7111009892351711
Quick ratio: 0.5306906683431915
Interest coverage ratio: 2.033427163969036
COGS to revenue (%): 36.7377466581795
R&D to revenue (%): 8.04105665181413
SG&A to revenue (%): 46.024824952259706
Free cash flow (dilution-adjusted): 14077000
Buyback yield (%): 0
Retained earnings: -180952000
Inventory turnover: 0.820923120688429
Receivables turnover: 1.625999430744948
Capitalized R&D asset: 5053000
ROCI (R&D-adjusted, %): 3.1948766486334197
FCF margin (%): 22.4013367281986
Rule of 40 score: 22.4013367281986
Financial ratios for MLAB — annual report dated 2025-03-31
Total revenue: 240978000
Gross profit: 150870000
Operating income: 16336000
Net income: -1974000
Capital expenditures: 4249000
Operating cash flow: 46808000
Depreciation & amortization: 24527000
Net tangible assets: -118805000
Owner earnings: 18304000
Capex to operating income (%): 26.01003917727718
Buffett classification: The Good
Stock price: 117.58
Shares outstanding: 5524931
Book value: 159830000
P/B ratio: 4.064452149033348
Market cap (USD): 649621386.98
Debt to equity: 1.1354063692673466
Current ratio: 0.6262693412538195
Quick ratio: 0.47156980538292176
Effective tax rate (%): 133.1152491192753
Interest coverage ratio: 1.3775191837423055
COGS to revenue (%): 37.392625052909395
R&D to revenue (%): 8.099494559669347
SG&A to revenue (%): 47.72883831719078
Free cash flow (dilution-adjusted): 29167000
Buyback yield (%): 0
Retained earnings: -188936000
Inventory turnover: 3.552454169130692
Receivables turnover: 5.7416726233023585
Capitalized R&D asset: 39210700
ROCI (R&D-adjusted, %): 5.212213477591122
Rosenberg metric: 0.9129533678756476
FCF margin (%): 12.103594519001733
Revenue growth (%): 11.46738703067252
Rule of 40 score: 23.57098154967425
Financial ratios for MLAB — quarterly report dated 2025-03-31
Total revenue: 62135000
Gross profit: 38412000
Operating income: 1469000
Net income: -7114000
Capital expenditures: 757000
Operating cash flow: 12665000
Depreciation & amortization: 7497000
Net tangible assets: -118805000
Owner earnings: -374000
Capex to operating income (%): 51.53165418652145
Buffett classification: The Good
Stock price: 117.58
Shares outstanding: 5524931
Book value: 159830000
P/B ratio: 4.064452149033348
Market cap (USD): 649621386.98
Debt to equity: 1.1354063692673466
Current ratio: 0.6262693412538195
Quick ratio: 0.47156980538292176
Effective tax rate (%): 1643.1670281995662
Interest coverage ratio: 0.5831679237792775
COGS to revenue (%): 38.1797698559588
R&D to revenue (%): 8.201496740967249
SG&A to revenue (%): 51.25452643437676
Free cash flow (dilution-adjusted): 8520000
Buyback yield (%): 0
Retained earnings: -188936000
Inventory turnover: 0.9352651291149221
Receivables turnover: 1.4804622349297116
Capitalized R&D asset: 8481510
ROCI (R&D-adjusted, %): 1.145154196524079
Rosenberg metric: -0.2655848011082525
FCF margin (%): 13.712078538665809
Revenue growth (%): -1.1218968809675367
Rule of 40 score: 12.590181657698272
Financial ratios for MLAB — quarterly report dated 2025-06-30
Total revenue: 59543000
Gross profit: 36939000
Operating income: 3064000
Net income: 4742000
Capital expenditures: 1009000
Operating cash flow: 1893000
Depreciation & amortization: 5957000
Net tangible assets: -112955000
Owner earnings: 9690000
Return on net tangible assets (%): -8.578637510513037
Capex to operating income (%): 32.93080939947781
Buffett classification: The Good
Stock price: 93.51
P/E ratio: 27.237257370835092
Shares outstanding: 5524931
Book value: 172496000
P/B ratio: 2.995062481506818
Market cap (USD): 516636297.81
Debt to equity: 1.1454932288284945
Current ratio: 0.6572705259073943
Quick ratio: 0.46926298045406506
Effective tax rate (%): 32.37307472903594
Interest coverage ratio: 1.3939945404913558
COGS to revenue (%): 37.96248089615908
R&D to revenue (%): 8.370421376148329
SG&A to revenue (%): 48.52123675327075
Free cash flow (dilution-adjusted): -2997000
Buyback yield (%): 0
Retained earnings: -185067000
Inventory turnover: 0.8042410873123177
Receivables turnover: 1.5240862086618203
Capitalized R&D asset: 10065810
ROCI (R&D-adjusted, %): 1.0136741618370904
Rosenberg metric: -0.2890502354788069
FCF margin (%): -5.033337252069932
Revenue growth (%): -4.171561921622274
Rule of 40 score: -9.204899173692207
Financial ratios for MLAB — quarterly report dated 2025-09-30
Total revenue: 60737000
Gross profit: 37331000
Operating income: 4724000
Net income: 2476000
Capital expenditures: 1092000
Operating cash flow: 8222000
Depreciation & amortization: 5849000
Net tangible assets: -103288000
Owner earnings: 7233000
Return on net tangible assets (%): -7.002749593369995
Capex to operating income (%): 23.116003386960205
Buffett classification: The Great
Stock price: 66.66
P/E ratio: 37.18617734854604
Shares outstanding: 5524931
Book value: 178468000
P/B ratio: 2.0636298970123494
Market cap (USD): 368291900.46
Debt to equity: 1.0670260214716363
Current ratio: 2.0174552231079823
Quick ratio: 1.4430893467232633
Effective tax rate (%): -23.861930965482742
Interest coverage ratio: 1.6505939902166318
COGS to revenue (%): 38.536641585853765
R&D to revenue (%): 8.31124355829231
SG&A to revenue (%): 45.37431878426659
Free cash flow (dilution-adjusted): 3318000
Buyback yield (%): 0
Retained earnings: -183473000
Inventory turnover: 0.8437939363351238
Receivables turnover: 1.5149406365359672
Capitalized R&D asset: 10068960
ROCI (R&D-adjusted, %): 1.2060781168669634
Rosenberg metric: 0.07865168539325842
FCF margin (%): 5.462897410145381
Revenue growth (%): 2.005273499823657
Rule of 40 score: 7.468170909969038
Financial ratios for MLAB — quarterly report dated 2025-12-31
Total revenue: 65126000
Gross profit: 41795000
Operating income: 7975000
Net income: 3630000
Capital expenditures: 732000
Operating cash flow: 18754000
Depreciation & amortization: 5715000
Net tangible assets: -92258000
Owner earnings: 8613000
Return on net tangible assets (%): -9.335775759283747
Capex to operating income (%): 9.178683385579937
Buffett classification: The Great
Stock price: 78.25
P/E ratio: 115.78089200589181
Shares outstanding: 5524931
Book value: 186691000
P/B ratio: 2.3157294714260463
Market cap (USD): 432325850.75
Debt to equity: 0.9694039884086538
Current ratio: 1.9419431933082085
Quick ratio: 1.4536814045408586
Effective tax rate (%): 21.01827676240209
Interest coverage ratio: 2.6268115942028984
COGS to revenue (%): 35.82440192856923
R&D to revenue (%): 7.721954365384025
SG&A to revenue (%): 44.208150354697054
Free cash flow (dilution-adjusted): 14640000
Buyback yield (%): 0
Retained earnings: -180727000
Inventory turnover: 0.8784592793403366
Receivables turnover: 1.6187209504635498
Capitalized R&D asset: 10055880
ROCI (R&D-adjusted, %): 2.0444211723059778
Rosenberg metric: 0.884310618066561
FCF margin (%): 22.4795012744526
Revenue growth (%): 7.226237713420155
Rule of 40 score: 29.705738987872753
Financial ratios for MLFDV.PA — annual report dated 2022-12-31
Total revenue: 4852425.531914894
Gross profit: 1279018.085106383
Operating income: 207341.48936170214
Net income: 148201.06382978725
Capital expenditures: 0
Depreciation & amortization: 137061.70212765958
Net tangible assets: 1145441.4893617022
Owner earnings: 285262.7659574468
Return on net tangible assets (%): 24.904176128316223
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6170212765957447
P/E ratio: 31.30465368353803
Shares outstanding: 7519000
Book value: 1156079.7872340428
P/B ratio: 4.0130300952871725
Market cap (USD): 4639382.978723404
Debt to equity: 0.9928923406780985
Current ratio: 1.579619662392861
Quick ratio: 1.444051786775877
Effective tax rate (%): 3.1662287469936468
Interest coverage ratio: 3.8465531192642444
COGS to revenue (%): 73.64167514381928
Buyback yield (%): 0
Retained earnings: 148201.06382978725
Inventory turnover: 14.10907112914472
Receivables turnover: 3.87745248053317
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.041994471400436
Rule of 40 score: 0
Financial ratios for MLFDV.PA — annual report dated 2023-12-31
Total revenue: 5264458.888888889
Gross profit: 1432976.6666666667
Operating income: 352502.2222222222
Net income: 165088.88888888888
Capital expenditures: 0
Depreciation & amortization: 66737.77777777778
Net tangible assets: 1118847.7777777778
Owner earnings: 231826.66666666666
Return on net tangible assets (%): 20.72012576430316
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6444444444444444
P/E ratio: 29.351325885045092
Shares outstanding: 7519000
Book value: 1129958.8888888885
P/B ratio: 4.2882779412820335
Market cap (USD): 4845577.777777777
Debt to equity: 1.5705330479083315
Current ratio: 1.4298879275809766
Quick ratio: 1.2761447169926492
Effective tax rate (%): 25.000126194430283
Interest coverage ratio: 3.6058739287581547
COGS to revenue (%): 72.78017177242864
Buyback yield (%): 0
Retained earnings: 165088.88888888888
Inventory turnover: 11.504839371565648
Receivables turnover: 5.093432736341941
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.818267761257612
Revenue growth (%): 8.491286558938626
Rule of 40 score: 8.491286558938626
Financial ratios for NNOX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.54
Shares outstanding: 69600783
Market cap (USD): 1011995384.8199999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NNOX — annual report dated 2022-12-31
Total revenue: 2436931.8181818184
Gross profit: -1954545.4545454546
Operating income: -24775000
Net income: -32171306.818181816
Capital expenditures: 2037215.9090909092
Operating cash flow: -12325284.090909092
Depreciation & amortization: 3270454.5454545454
Net tangible assets: 33534375
Owner earnings: -30938068.18181818
Return on net tangible assets (%): -92.25777484094509
Buffett classification: The Gruesome
Stock price: 7.38
Shares outstanding: 69600783
Book value: 61556818.18181817
P/B ratio: 8.344384809215434
Market cap (USD): 513653778.54
Debt to equity: 0.021317149713863767
Current ratio: 3.2887054319215125
Quick ratio: 3.2887054319215125
COGS to revenue (%): 180.20517603170902
R&D to revenue (%): 309.0114245744929
SG&A to revenue (%): 531.9421776637911
Free cash flow (dilution-adjusted): -19653125
Buyback yield (%): 0
Retained earnings: -73709375
Receivables turnover: 8.779938587512795
Capitalized R&D asset: 7530397.7272727275
ROCI (R&D-adjusted, %): -27.23019770316591
FCF margin (%): -806.4700396362788
Rule of 40 score: -806.4700396362788
Financial ratios for NNOX — annual report dated 2023-12-31
Total revenue: 2736187.8453038675
Gross profit: -1820994.4751381215
Operating income: -16479834.254143646
Net income: -16788950.276243094
Capital expenditures: 912430.9392265193
Operating cash flow: -12369337.016574586
Depreciation & amortization: 3262430.9392265193
Net tangible assets: 31742265.193370163
Owner earnings: -14438950.276243094
Return on net tangible assets (%): -45.48809036873298
Buffett classification: The Gruesome
Stock price: 6.37
Shares outstanding: 69600783
Book value: 54009392.26519337
P/B ratio: 8.208886808669456
Market cap (USD): 443356987.71
Debt to equity: 0.0429432163425637
Current ratio: 5.709546508631796
Quick ratio: 5.557781499613501
COGS to revenue (%): 166.55224634023222
R&D to revenue (%): 262.9883897021706
SG&A to revenue (%): 287.12771327612313
Free cash flow (dilution-adjusted): -15170718.2320442
Buyback yield (%): 0
Retained earnings: -88462154.6961326
Inventory turnover: 7.002122241086588
Receivables turnover: 6.6745283018867925
Capitalized R&D asset: 12241222.830863887
ROCI (R&D-adjusted, %): -20.763924903421284
Rosenberg metric: 0.01773491709789159
FCF margin (%): -554.44724886421
Revenue growth (%): 12.280032821981964
Rule of 40 score: -542.167216042228
Financial ratios for NNOX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.08
Shares outstanding: 69600783
Market cap (USD): 423172760.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NNOX — annual report dated 2024-12-31
Total revenue: 3091232.8767123288
Gross profit: -2906575.3424657537
Operating income: -15546849.315068493
Net income: -14661917.808219178
Capital expenditures: 758082.1917808219
Operating cash flow: -10026849.315068493
Depreciation & amortization: 3214520.5479452056
Net tangible assets: 32636712.328767125
Owner earnings: -12205479.452054795
Return on net tangible assets (%): -37.39800543970988
Buffett classification: The Gruesome
Stock price: 7.2
Shares outstanding: 69600783
Book value: 51813424.65753425
P/B ratio: 9.671733549987044
Market cap (USD): 501125637.6
Debt to equity: 0.03937203559663492
Current ratio: 5.631262525050101
Quick ratio: 5.524405954766677
COGS to revenue (%): 194.02641141540371
R&D to revenue (%): 178.87086767703627
SG&A to revenue (%): 228.21058229194367
Free cash flow (dilution-adjusted): -12774246.575342465
Buyback yield (%): 0
Retained earnings: -102396986.30136986
Inventory turnover: 14.663094440723377
Receivables turnover: 6.2509695290858724
Capitalized R&D asset: 12835570.075399227
ROCI (R&D-adjusted, %): -25.201053378135192
Rosenberg metric: -0.15086194248247642
FCF margin (%): -413.24115926615264
Revenue growth (%): 12.97590119837082
Rule of 40 score: -400.2652580677818
Financial ratios for NNOX — quarterly report dated 2024-12-31
Total revenue: 821917.8082191781
Gross profit: -791780.8219178083
Operating income: -4102739.7260273974
Net income: -3852328.7671232875
Capital expenditures: 284109.5890410959
Operating cash flow: -2885479.4520547944
Depreciation & amortization: 804109.5890410959
Net tangible assets: 32636712.328767125
Owner earnings: -3332328.7671232875
Return on net tangible assets (%): -10.210369027232128
Buffett classification: The Gruesome
Stock price: 7.2
Shares outstanding: 69600783
Book value: 51813424.65753425
P/B ratio: 9.671733549987044
Market cap (USD): 501125637.6
Debt to equity: 0.03937203559663492
Current ratio: 5.631262525050101
Quick ratio: 5.524405954766677
COGS to revenue (%): 196.33333333333331
R&D to revenue (%): 180.03333333333333
SG&A to revenue (%): 247.56666666666666
Free cash flow (dilution-adjusted): -3557534.2465753425
Buyback yield (%): 0
Retained earnings: -102396986.30136986
Inventory turnover: 3.9450770261219024
Receivables turnover: 1.662049861495845
Capitalized R&D asset: 1479726.0273972603
ROCI (R&D-adjusted, %): -5.646764069747623
FCF margin (%): -432.8333333333333
Rule of 40 score: -432.8333333333333
Financial ratios for NNOX — quarterly report dated 2025-03-31
Total revenue: 762872.6287262873
Gross profit: -826287.2628726288
Operating income: -3818428.184281843
Net income: -3587804.8780487804
Capital expenditures: 142818.42818428183
Operating cash flow: -2798644.9864498647
Depreciation & amortization: 797560.9756097561
Net tangible assets: 29762330.623306233
Owner earnings: -2933062.3306233063
Return on net tangible assets (%): -9.85494841699826
Buffett classification: The Gruesome
Stock price: 4.99
Shares outstanding: 69600783
Book value: 48012195.12195122
P/B ratio: 7.2337435580238765
Market cap (USD): 347307907.17
Debt to equity: 0.04174639460390032
Current ratio: 5.297404722936638
Quick ratio: 5.161172161172161
COGS to revenue (%): 208.31261101243336
R&D to revenue (%): 176.83836589698046
SG&A to revenue (%): 215.87921847246895
Free cash flow (dilution-adjusted): -3257452.574525745
Buyback yield (%): 0
Retained earnings: -104874796.74796748
Inventory turnover: 3.3546910755148738
Receivables turnover: 1.6347270615563299
Capitalized R&D asset: 2340467.9288710696
ROCI (R&D-adjusted, %): -6.539513243908762
Rosenberg metric: -0.023319479630641505
FCF margin (%): -426.9982238010657
Revenue growth (%): -7.183830171635051
Rule of 40 score: -434.18205397270077
Financial ratios for NNOX — quarterly report dated 2025-06-30
Total revenue: 896755.1622418879
Gross profit: -955752.2123893804
Operating income: -4274631.268436578
Net income: -4342772.861356932
Capital expenditures: 310324.4837758112
Operating cash flow: -2746607.669616519
Depreciation & amortization: 869911.5044247787
Net tangible assets: 29164896.75516224
Owner earnings: -3783185.8407079643
Return on net tangible assets (%): -12.97171004055872
Buffett classification: The Gruesome
Stock price: 5.17
Shares outstanding: 69600783
Book value: 48247197.64011799
P/B ratio: 7.458175100532534
Market cap (USD): 359836048.11
Debt to equity: 0.048631066655253796
Current ratio: 4.191948658109685
Quick ratio: 4.027785880980163
Interest coverage ratio: -97.25503355704697
COGS to revenue (%): 206.57894736842107
R&D to revenue (%): 159.01315789473685
SG&A to revenue (%): 209.40789473684208
Free cash flow (dilution-adjusted): -3384660.766961652
Buyback yield (%): 0
Retained earnings: -118498525.07374631
Inventory turnover: 2.7898711683696136
Receivables turnover: 1.6170212765957446
Capitalized R&D asset: 2818132.7897509793
ROCI (R&D-adjusted, %): -8.032750141340706
Rosenberg metric: -0.09596738925608954
FCF margin (%): -377.4342105263158
Revenue growth (%): 17.549788585171093
Rule of 40 score: -359.8844219411447
Financial ratios for NNOX — quarterly report dated 2025-09-30
Total revenue: 1041389.7280966768
Gross profit: -870694.8640483384
Operating income: -4300604.229607251
Net income: -4134138.9728096677
Capital expenditures: 525679.7583081571
Operating cash flow: -3245015.105740181
Depreciation & amortization: 893655.5891238671
Net tangible assets: 28602114.80362538
Owner earnings: -3766163.1419939576
Return on net tangible assets (%): -13.167428939613194
Buffett classification: The Gruesome
Stock price: 3.7
Shares outstanding: 69600783
Book value: 47344108.7613293
P/B ratio: 5.439386310939386
Market cap (USD): 257522897.10000002
Debt to equity: 0.05027790363029565
Current ratio: 4.141819355880217
Quick ratio: 3.92646702720155
COGS to revenue (%): 183.60893530606324
R&D to revenue (%): 133.04322599361765
SG&A to revenue (%): 196.22860458369595
Free cash flow (dilution-adjusted): -4102719.0332326284
Buyback yield (%): 0
Retained earnings: -125496676.73716012
Inventory turnover: 2.3721889055472265
Receivables turnover: 1.7795560144553433
Capitalized R&D asset: 2786077.8116793814
ROCI (R&D-adjusted, %): -8.234695062131314
Rosenberg metric: 0.05964923683825664
FCF margin (%): -393.96576733391356
Revenue growth (%): 16.128657179201785
Rule of 40 score: -377.83711015471175
Financial ratios for NNOX — quarterly report dated 2025-12-31
Total revenue: 1169496.8553459118
Gross profit: -1137421.3836477988
Operating income: -5623584.905660377
Net income: -10494654.088050313
Capital expenditures: 279245.2830188679
Operating cash flow: -3274842.767295597
Depreciation & amortization: 895283.0188679245
Net tangible assets: 25015094.33962264
Owner earnings: -9878616.352201257
Return on net tangible assets (%): -39.49062201438125
Buffett classification: The Gruesome
Stock price: 2.8
Shares outstanding: 69600783
Book value: 43940880.50314465
P/B ratio: 4.4350998470786935
Market cap (USD): 194882192.39999998
Debt to equity: 0.05618612773022643
Current ratio: 3.9550568450971104
Quick ratio: 3.7732709616295597
COGS to revenue (%): 197.25732723850498
R&D to revenue (%): 130.08873353051897
SG&A to revenue (%): 239.93008873353054
Free cash flow (dilution-adjusted): -3810062.8930817605
Buyback yield (%): 0
Retained earnings: -141121698.11320755
Inventory turnover: 2.38957654723127
Receivables turnover: 1.8474913065076997
Capitalized R&D asset: 2920234.007395566
ROCI (R&D-adjusted, %): -11.411380484411378
Rosenberg metric: -0.1925130352974736
FCF margin (%): -325.7865017477817
Revenue growth (%): 12.301554719900436
Rule of 40 score: -313.4849470278813
Financial ratios for NNOX — annual report dated 2025-12-31
Total revenue: 4094654.088050314
Gross profit: -4021383.647798742
Operating income: -19087735.8490566
Net income: -23590566.03773585
Capital expenditures: 1322955.9748427672
Operating cash flow: -12827987.421383647
Depreciation & amortization: 3678301.8867924525
Net tangible assets: 25015094.33962264
Owner earnings: -21235220.125786167
Return on net tangible assets (%): -84.88962638909842
Buffett classification: The Gruesome
Stock price: 2.8
Shares outstanding: 69600783
Book value: 43940880.50314465
P/B ratio: 4.4350998470786935
Market cap (USD): 194882192.39999998
Debt to equity: 0.05618612773022643
Current ratio: 3.9550568450971104
Quick ratio: 3.7732709616295597
COGS to revenue (%): 198.21058290453882
R&D to revenue (%): 147.73058904846016
SG&A to revenue (%): 208.117656094002
Free cash flow (dilution-adjusted): -15468553.459119495
Buyback yield (%): 0
Retained earnings: -141121698.11320755
Inventory turnover: 8.406840390879479
Receivables turnover: 6.468455042225534
Capitalized R&D asset: 12128330.29634908
ROCI (R&D-adjusted, %): -33.37792790284835
Rosenberg metric: -0.2016177937996932
FCF margin (%): -377.77436448813455
Revenue growth (%): 32.46022707953246
Rule of 40 score: -345.3141374086021
Financial ratios for NXG — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.83
Shares outstanding: 5682883
Market cap (USD): 152471750.89
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXG — annual report dated 2022-11-30
Total revenue: 10865501
Net income: 10553181
Capital expenditures: 0
Operating cash flow: 22059365
Net tangible assets: 142434269
Owner earnings: 10553181
Return on net tangible assets (%): 7.409158676554166
Buffett classification: The Gruesome
Stock price: 26.9
P/E ratio: 14.48563733532098
Shares outstanding: 5682883
Book value: 142434269
P/B ratio: 1.073263855484104
Market cap (USD): 152869552.7
Debt to equity: 0.29073059658136063
COGS to revenue (%): 0
SG&A to revenue (%): 6.984353505650591
Free cash flow (dilution-adjusted): 22059365
Buyback yield (%): 0
Retained earnings: -5577457
Receivables turnover: 28.217463116425105
Capitalized R&D asset: 0
FCF margin (%): 203.022069575991
Rule of 40 score: 203.022069575991
Financial ratios for NXG — annual report dated 2023-11-30
Total revenue: -28128268
Net income: -28511292
Capital expenditures: 0
Operating cash flow: 14423973
Net tangible assets: 103681589
Owner earnings: -28511292
Return on net tangible assets (%): -27.49889568146954
Buffett classification: The Gruesome
Stock price: 22.47
Shares outstanding: 5682883
Book value: 103681589
P/B ratio: 1.231601311685144
Market cap (USD): 127694381.00999999
Debt to equity: 0.3550292810423652
Free cash flow (dilution-adjusted): 14423973
Buyback yield (%): 0
Retained earnings: -40725289
Receivables turnover: -88.72794834346423
Capitalized R&D asset: 0
Revenue growth (%): -358.8768617296156
Rule of 40 score: -358.8768617296156
Financial ratios for NXG — annual report dated 2024-11-30
Total revenue: 62597383
Net income: 61796306
Capital expenditures: 0
Operating cash flow: -30497868
Net tangible assets: 177964351
Owner earnings: 61796306
Return on net tangible assets (%): 34.72398019758462
Buffett classification: The Gruesome
Stock price: 44.1
P/E ratio: 4.055503581395302
Shares outstanding: 5682883
Book value: 177964351
P/B ratio: 1.4082322605160402
Market cap (USD): 250615140.3
Debt to equity: 0.3079830297023925
COGS to revenue (%): 0
SG&A to revenue (%): 1.93938938309929
Free cash flow (dilution-adjusted): -30497868
Buyback yield (%): 0
Retained earnings: 19648712
Receivables turnover: 5.025757925614388
Capitalized R&D asset: 0
FCF margin (%): -48.72067575093355
Rule of 40 score: -48.72067575093355
Financial ratios for NXG — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 177964351
Buffett classification: The Gruesome
Stock price: 44.1
Shares outstanding: 5682883
Book value: 177964351
P/B ratio: 1.4082322605160402
Market cap (USD): 250615140.3
Debt to equity: 0.3079830297023925
Buyback yield (%): 0
Retained earnings: 19648712
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXG — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 188388984
Buffett classification: The Gruesome
Stock price: 41.55
Shares outstanding: 5682883
Book value: 188388984
P/B ratio: 1.253384267150143
Market cap (USD): 236123788.64999998
Debt to equity: 0.2856324125618725
Buyback yield (%): 0
Retained earnings: 13720585
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXS.V — annual report dated 2022-01-31
Total revenue: 0
Gross profit: -3126.5625
Operating income: -2739070.3125
Net income: -2720553.125
Capital expenditures: 78125
Operating cash flow: -2535324.21875
Depreciation & amortization: 21735.9375
Net tangible assets: 5286543.75
Owner earnings: -2776942.1875
Return on net tangible assets (%): -52.52850101732346
Buffett classification: The Gruesome
Stock price: 4.8828125
Shares outstanding: 24005125
Book value: 5286543.75
P/B ratio: 22.171863122113102
Market cap (USD): 117212524.4140625
Debt to equity: 0.05222516601702199
Current ratio: 1.4793845854600587
Quick ratio: 1.4793845854600587
Interest coverage ratio: -379.64374661613425
Free cash flow (dilution-adjusted): -2681225
Buyback yield (%): 0
Retained earnings: -22193807.8125
Receivables turnover: 0
Capitalized R&D asset: 562317.1875
ROCI (R&D-adjusted, %): -40.154153769765315
Rule of 40 score: 0
Financial ratios for NXS.V — annual report dated 2023-01-31
Total revenue: 0
Gross profit: -2986.567164179104
Operating income: -1319185.0746268656
Net income: -1754508.9552238805
Capital expenditures: 149253.73134328358
Operating cash flow: -284564.1791044776
Depreciation & amortization: 23272.38805970149
Net tangible assets: 3751.4925373134324
Owner earnings: -1880490.2985074625
Return on net tangible assets (%): -50126.45713148996
Buffett classification: The Gruesome
Stock price: 1.8656716417910446
Shares outstanding: 24005125
Book value: 3751.4925373136066
P/B ratio: 11938.096777401475
Market cap (USD): 44785680.97014925
Debt to equity: 141.2033021682847
Current ratio: 0.16173472249300927
Quick ratio: 0.16173472249300927
Interest coverage ratio: -49.78477483313149
Free cash flow (dilution-adjusted): -284564.1791044776
Buyback yield (%): 0
Retained earnings: -22954564.179104477
Receivables turnover: 0
Capitalized R&D asset: 451218.187266791
ROCI (R&D-adjusted, %): -311.2717623632675
Rosenberg metric: 0.0002489615095055153
Rule of 40 score: 0
Financial ratios for NXS.V — annual report dated 2024-01-31
Total revenue: 0
Gross profit: -2986.567164179104
Operating income: -685899.2537313432
Net income: -835952.2388059701
Capital expenditures: 0
Operating cash flow: -373048.50746268657
Depreciation & amortization: 23272.38805970149
Net tangible assets: -474066.41791044775
Owner earnings: -812679.8507462685
Buffett classification: The Gruesome
Stock price: 0.3731343283582089
Shares outstanding: 24005125
Book value: -474066.4179104478
Market cap (USD): 8957136.194029849
Debt to equity: -2.3788325522747766
Current ratio: 0.04655957305890938
Quick ratio: 0.04655957305890938
Interest coverage ratio: -21.83199125869973
Free cash flow (dilution-adjusted): -373048.50746268657
Buyback yield (%): 0
Retained earnings: -23790516.417910445
Receivables turnover: 0
Capitalized R&D asset: 248516.3733675373
Rosenberg metric: 0
Rule of 40 score: 0
Financial ratios for NXS.V — quarterly report dated 2024-10-31
Total revenue: 0
Gross profit: 0
Operating income: -30512.23021582734
Net income: -40530.215827338136
Capital expenditures: 0
Operating cash flow: -5938.84892086331
Depreciation & amortization: 0
Net tangible assets: -469025.17985611514
Owner earnings: -40530.215827338136
Buffett classification: The Gruesome
Stock price: 0.1798561151079137
Shares outstanding: 24005125
Book value: -469025.179856115
Market cap (USD): 4317468.525179856
Debt to equity: -0.7899439369885498
Current ratio: 0.012206465148440692
Quick ratio: 0.012206465148440692
Interest coverage ratio: -5.445114905636154
Free cash flow (dilution-adjusted): -5938.84892086331
Buyback yield (%): 0
Retained earnings: -23120836.690647483
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXS.V — annual report dated 2025-01-31
Total revenue: 0
Gross profit: -1380
Operating income: -235076.55172413794
Net income: -158585.5172413793
Capital expenditures: 0
Operating cash flow: -54746.89655172414
Depreciation & amortization: 10753.793103448275
Net tangible assets: -534627.5862068966
Owner earnings: -147831.724137931
Buffett classification: The Gruesome
Stock price: 0.1724137931034483
Shares outstanding: 24005125
Book value: -534627.5862068967
Market cap (USD): 4138814.655172414
Debt to equity: -1.7899562699139584
Current ratio: 0.008655016344826887
Quick ratio: 0.008655016344826887
Interest coverage ratio: -9.655845443471856
Free cash flow (dilution-adjusted): -54746.89655172414
Buyback yield (%): 0
Retained earnings: -22144304.137931034
Receivables turnover: 0
Capitalized R&D asset: 33323.67164179104
Rosenberg metric: 0.12301714285714282
Rule of 40 score: 0
Financial ratios for NXS.V — quarterly report dated 2025-01-31
Total revenue: 0
Gross profit: 0
Operating income: -62825.51724137931
Net income: 19808.275862068967
Capital expenditures: 0
Operating cash flow: -6144.137931034483
Depreciation & amortization: 0
Net tangible assets: -534627.5862068966
Owner earnings: 19808.275862068967
Return on net tangible assets (%): -3.7050605642342074
Buffett classification: The Gruesome
Stock price: 0.1724137931034483
P/E ratio: 52.235927599052985
Shares outstanding: 24005125
Book value: -534627.5862068967
Market cap (USD): 4138814.655172414
Debt to equity: -1.7899562699139584
Current ratio: 0.008655016344826887
Quick ratio: 0.008655016344826887
Interest coverage ratio: -11.65817762989506
Free cash flow (dilution-adjusted): -6144.137931034483
Buyback yield (%): 0
Retained earnings: -22144304.137931034
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXS.V — quarterly report dated 2025-04-30
Total revenue: 0
Gross profit: 0
Operating income: -112010.14492753624
Net income: 259588.40579710147
Capital expenditures: 0
Operating cash flow: -173055.07246376813
Depreciation & amortization: 0
Net tangible assets: 76827.53623188406
Owner earnings: 259588.40579710147
Return on net tangible assets (%): 337.88458999075664
Buffett classification: The Gruesome
Stock price: 0.1811594202898551
P/E ratio: 4.188124769702316
Shares outstanding: 24005125
Book value: 76827.53623188403
P/B ratio: 56.60411282563999
Market cap (USD): 4348754.528985508
Debt to equity: 9.517156816509784
Current ratio: 0.24472397662549386
Quick ratio: 0.24472397662549386
Interest coverage ratio: -70.71088746569076
Free cash flow (dilution-adjusted): -173055.07246376813
Buyback yield (%): 0
Retained earnings: -23007977.536231887
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -145.79426911395754
Rule of 40 score: 0
Financial ratios for NXS.V — quarterly report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1811594202898551
P/E ratio: 18.205797594238845
Shares outstanding: 24005125
Market cap (USD): 4348754.528985508
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXS.V — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: 0
Operating income: -87262.85714285714
Net income: -90882.85714285714
Capital expenditures: 0
Operating cash flow: -66766.42857142858
Depreciation & amortization: 0
Net tangible assets: -110387.14285714287
Owner earnings: -90882.85714285714
Buffett classification: The Gruesome
Stock price: 0.10000000000000002
P/E ratio: 12.733880425794815
Shares outstanding: 24005125
Book value: -110387.14285714284
Market cap (USD): 2400512.5000000005
Debt to equity: -7.482949618873835
Current ratio: 0.04234128443796743
Quick ratio: 0.04234128443796743
Interest coverage ratio: -26.79122807017544
Free cash flow (dilution-adjusted): -66766.42857142858
Buyback yield (%): 0
Retained earnings: -22865409.285714287
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXS.V — quarterly report dated 2026-01-31
Total revenue: 0
Gross profit: 0
Operating income: -208808.14814814815
Net income: -1145723.7037037036
Capital expenditures: 0
Operating cash flow: -234947.4074074074
Depreciation & amortization: 0
Net tangible assets: -441608.14814814815
Owner earnings: -1145723.7037037036
Buffett classification: The Gruesome
Stock price: 0.30370370370370364
Shares outstanding: 24005125
Book value: -441608.14814814815
Market cap (USD): 7290445.3703703685
Debt to equity: -1.7049286194732718
Current ratio: 0.4853141055088372
Quick ratio: 0.4853141055088372
Interest coverage ratio: -162.2861255037421
Free cash flow (dilution-adjusted): -234947.4074074074
Buyback yield (%): 0
Retained earnings: -24858000
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXS.V — annual report dated 2026-01-31
Total revenue: 0
Gross profit: 0
Operating income: -512638.5185185185
Net income: -1073377.037037037
Capital expenditures: 0
Operating cash flow: -652314.8148148147
Depreciation & amortization: 0
Net tangible assets: -441608.14814814815
Owner earnings: -1073377.037037037
Buffett classification: The Gruesome
Stock price: 0.30370370370370364
Shares outstanding: 24005125
Book value: -441608.14814814815
Market cap (USD): 7290445.3703703685
Debt to equity: -1.7049286194732718
Current ratio: 0.4853141055088372
Quick ratio: 0.4853141055088372
Interest coverage ratio: -81.58222327006955
Free cash flow (dilution-adjusted): -657821.4814814813
Buyback yield (%): 0
Retained earnings: -24858000
Receivables turnover: 0
Capitalized R&D asset: 4309.701492537313
Rule of 40 score: 0
Financial ratios for OFIX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.09
Shares outstanding: 40421652
Market cap (USD): 1256709160.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OFIX — annual report dated 2022-12-31
Total revenue: 460713000
Gross profit: 337169000
Operating income: -28868000
Net income: -19749000
Capital expenditures: 23160000
Operating cash flow: -11538000
Depreciation & amortization: 32075000
Net tangible assets: 218155000
Owner earnings: -10834000
Return on net tangible assets (%): -4.966193761316495
Buffett classification: The Gruesome
Stock price: 20.53
Shares outstanding: 40421652
Book value: 336860000
P/B ratio: 2.4635056568307308
Market cap (USD): 829856515.5600001
Debt to equity: 0.06391082348750222
Current ratio: 3.0612025255907396
Quick ratio: 1.8635798335406104
Interest coverage ratio: -22.41304347826087
COGS to revenue (%): 26.81582677284991
R&D to revenue (%): 10.649797162224639
SG&A to revenue (%): 67.02133432310353
Free cash flow (dilution-adjusted): -53141000
Buyback yield (%): 0
Retained earnings: 1251000
Inventory turnover: 1.233589615576635
Receivables turnover: 5.560338897136029
Capitalized R&D asset: 49065000
ROCI (R&D-adjusted, %): 0.9059825028886741
FCF margin (%): -11.534512809493112
Rule of 40 score: -11.534512809493112
Financial ratios for OFIX — annual report dated 2023-12-31
Total revenue: 746641000
Gross profit: 486273000
Operating income: -141761000
Net income: -151395000
Capital expenditures: 62050000
Operating cash flow: -45753000
Depreciation & amortization: 60561000
Net tangible assets: 286306000
Owner earnings: -152884000
Return on net tangible assets (%): -53.398811062289994
Buffett classification: The Gruesome
Stock price: 13.48
Shares outstanding: 40421652
Book value: 598730000
P/B ratio: 0.9100660881532577
Market cap (USD): 544883868.96
Debt to equity: 0.1955372204499524
Current ratio: 2.544700193072393
Quick ratio: 1.2000568928054811
Interest coverage ratio: -16.424632139960607
COGS to revenue (%): 34.871913007723926
R&D to revenue (%): 10.745592594031134
SG&A to revenue (%): 71.03748655645752
Free cash flow (dilution-adjusted): -143510000
Buyback yield (%): 0
Retained earnings: -150144000
Inventory turnover: 1.171952503983508
Receivables turnover: 5.828670236849912
Capitalized R&D asset: 113104550
ROCI (R&D-adjusted, %): -11.982258366305576
Rosenberg metric: 3.038907571588709
FCF margin (%): -19.2207499989955
Revenue growth (%): 62.062064669327754
Rule of 40 score: 42.84131467033225
Financial ratios for OFIX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.62
Shares outstanding: 40421652
Market cap (USD): 631386204.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0